Triggers, Facilitators, and Aggravators: Redefining Parkinson's Disease Pathogenesis

Michaela E. Johnson, Benjamin Stecher, Viviane Labrie, Lena Brundin, Patrik Brundin

Research output: Contribution to journalReview articlepeer-review

240 Citations (Scopus)
107 Downloads (Pure)

Abstract

We hypothesize that Parkinson's disease (PD) pathogenesis can be divided into three temporal phases. During the first phase, ‘triggers’ such as viral infections or environmental toxins, spark the disease process in the brain and/or peripheral tissues. Triggers alone, however, may be insufficient, requiring ‘facilitators’ like peripheral inflammation for PD pathology to develop. Once the disease manifests, ‘aggravators’ spur further neurodegeneration and exacerbate symptoms. Aggravators are proposed to include impaired autophagy and cell-to-cell propagation of α-synuclein pathology. We believe clinical trials need to consider these three phases and target potential therapies at the appropriate stage of the disease process in order to be effective.

Original languageEnglish
Pages (from-to)4-13
Number of pages10
JournalTrends in Neurosciences
Volume42
Issue number1
DOIs
Publication statusPublished - Jan 2019
Externally publishedYes

Keywords

  • Clinical trials
  • genetics
  • inflammation
  • Parkinson's disease
  • α-synuclein

Fingerprint

Dive into the research topics of 'Triggers, Facilitators, and Aggravators: Redefining Parkinson's Disease Pathogenesis'. Together they form a unique fingerprint.

Cite this